/CANB.V
CANB.V Stock - CanadaBis Capital Inc.
Healthcare|Drug Manufacturers - Specialty & GenericTSXV
$0.03+0.00%
+$0.00 (+0.00%) • Dec 22
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.03
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CANB.V
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.02 – $0.03
TARGET (TP)$0.03
STOP LOSS$0.02
RISK/REWARD1:1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.35
52W High$0.11
52W Low$0.03
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $16.90M | $17.95M | $22.22M | $11.67M | $6.87M |
| Gross Profit | $6.98M | $8.82M | $11.78M | $5.57M | $2.52M |
| Gross Margin | 41.3% | 49.1% | 53.0% | 47.8% | 36.7% |
| Operating Income | $428,466 | $833,784 | $4.68M | $1.04M | $-2,285,648 |
| Net Income | $-835,204 | $600,285 | $4.44M | $608,332 | $-2,676,773 |
| Net Margin | -4.9% | 3.3% | 20.0% | 5.2% | -39.0% |
| EPS | $-0.01 | $0.00 | $0.03 | $0.00 | $-0.02 |
Company Overview
CanadaBis Capital Inc. engages in the production and sale of recreational cannabis and cannabis extracts in Canada. It operates through three segments: Cultivation and Wholesale, Retail, and Extraction and Tolling. The Cultivation and Wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. The Retail segment sells cannabis and cannabis related products to end consumers on premise owned and operated by the company. The Extraction and Tolling segment provides cannabinoid extraction services to other licensed producers. CanadaBis Capital Inc. is based in Red Deer, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CANB.VBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q2 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 26, 2026 | — | — | — | — |
Q4 2025 | Dec 30, 2025 | — | — | — | — |
Q2 2025 | Jun 30, 2025 | — | — | — | — |
Q2 2025 | Jun 26, 2025 | — | $-0.00 | — | — |
Q1 2025 | Mar 28, 2025 | — | $0.00 | — | — |
Q4 2024 | Dec 30, 2024 | — | $0.00 | — | — |
Q3 2024 | Aug 29, 2024 | — | $-0.00 | — | — |
Q2 2024 | Jun 26, 2024 | — | $0.00 | — | — |
Q2 2024 | Apr 1, 2024 | — | $0.00 | — | — |
Q1 2024 | Jan 2, 2024 | — | $0.01 | — | — |
Q4 2023 | Nov 29, 2023 | — | $0.01 | — | — |
Q2 2023 | Jun 29, 2023 | — | $0.01 | — | — |
Q2 2023 | Apr 3, 2023 | — | $0.01 | — | — |
Q4 2022 | Dec 29, 2022 | — | $0.01 | — | — |
Q4 2022 | Nov 29, 2022 | — | $0.00 | — | — |
Q2 2022 | Apr 30, 2022 | — | $0.00 | — | — |
Q1 2022 | Jan 31, 2022 | — | $0.00 | — | — |
Q4 2021 | Oct 31, 2021 | — | $-0.00 | — | — |
Q3 2021 | Jul 31, 2021 | — | $-0.01 | — | — |
Q2 2021 | Apr 30, 2021 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about CANB.V
What is CANB.V's current stock price?
CanadaBis Capital Inc. (CANB.V) is currently trading at $0.03 per share. The stock has moved +0.00% today.
What is the analyst price target for CANB.V?
No analyst price targets are currently available for this stock.
What sector is CanadaBis Capital Inc. in?
CanadaBis Capital Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the TSXV exchange.
What is CANB.V's market cap?
CanadaBis Capital Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does CANB.V pay dividends?
No, CanadaBis Capital Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAVCR.V
Avricore Health Inc.
$0.05
Mkt Cap: $0.0B
AVNT.TO
Avant Brands Inc.
$0.98
Mkt Cap: $0.0B
AYUR.CN
Ayurcann Holdings Corp.
$0.03
Mkt Cap: $0.0B
CDVA.CN
CordovaCann Corp.
$0.04
Mkt Cap: $0.0B
KNE.V
Kane Biotech Inc.
$0.04
Mkt Cap: $0.0B
MUSH.V
Mercanto Holdings Inc.
$0.14
Mkt Cap: $0.0B
MVMD.CN
Mountain Valley MD Holdings Inc.
$0.01
Mkt Cap: $0.0B
RVV.CN
Revive Therapeutics Ltd.
$0.01
Mkt Cap: $0.0B
TELO.V
Telo Genomics Corp.
$0.06
Mkt Cap: $0.0B
TGIF.CN
1933 Industries Inc.
$0.01
Mkt Cap: $0.0B
Explore stocks similar to CANB.V for comparison